Is it appropriate to use clindamycin and levofloxacin together for an unresolved otitis media?

Clindamycin and Levofloxacin for Unresolved Otitis Media

For unresolved acute otitis media (AOM) after multiple antibiotic failures, the combination of clindamycin with levofloxacin may be considered as a salvage regimen, but this should only be used after standard escalation therapies have failed and ideally after tympanocentesis with culture. This combination is not FDA-approved for AOM and represents off-label use, particularly concerning for levofloxacin in children 1.

Treatment Algorithm for Unresolved AOM

First-Line Failure (48-72 hours without improvement)

• If initially on amoxicillin → switch to high-dose amoxicillin-clavulanate (90 mg/kg/day) 1
• If initially on amoxicillin-clavulanate or oral cephalosporins → switch to IM ceftriaxone (50 mg/kg) for 3 days 1

Second-Line Failure

• Strongly consider tympanocentesis for culture and susceptibility testing 1
• If tympanocentesis unavailable, the guideline states: clindamycin may be used with or without an antibiotic covering nontypeable H. influenzae and M. catarrhalis (such as cefdinir, cefixime, or cefuroxime) 1

Third-Line/Salvage Therapy (Multiple Failures)

This is where your proposed regimen fits:

Clindamycin + Levofloxacin combination:

• Clindamycin covers resistant Gram-positive organisms including some pneumococcal strains
• Levofloxacin provides coverage for H. influenzae, M. catarrhalis, and multidrug-resistant S. pneumoniae serotype 19A 1

Critical Caveats and Concerns

Levofloxacin-Specific Issues

Levofloxacin is NOT FDA-approved for AOM treatment in children 1, 2, 1. The 2013 AAP guideline explicitly states that levofloxacin should only be considered when:

• Multiple conventional antibiotics have failed
• Tympanocentesis is not available
• Consultation with pediatric subspecialists (otolaryngology, infectious disease) has occurred 1

FDA warnings for levofloxacin include:

• Tendon rupture and tendinitis
• Peripheral neuropathy (potentially irreversible)
• CNS effects (seizures, psychosis)
• QT prolongation
• Musculoskeletal disorders in pediatric patients 3

Coverage Limitations

Important gap: S. pneumoniae serotype 19A is often multidrug-resistant and may not respond to clindamycin alone 1. This is precisely why levofloxacin is mentioned as an option—it provides coverage when clindamycin fails against this serotype.

Evidence for the Combination

• In vitro studies show synergy between levofloxacin and clindamycin against some anaerobes at concentrations at or below MIC 4
• Clinical studies demonstrate levofloxacin achieves 88-94% bacterial eradication in children with recurrent/persistent AOM 5, 6
• Levofloxacin was noninferior to amoxicillin-clavulanate for recurrent/persistent AOM in children 6 months to 5 years 6

Practical Recommendations

Before Using This Combination:

1. Confirm true treatment failure (not just persistent middle ear effusion, which is common and benign) 1
2. Perform tympanocentesis if available for culture-directed therapy 1
3. Consult pediatric infectious disease and/or otolaryngology 1
4. Document informed consent discussing off-label use and FDA warnings for levofloxacin 3

If Proceeding with Clindamycin + Levofloxacin:

• Clindamycin: 30-40 mg/kg/day divided TID
• Levofloxacin: 10 mg/kg twice daily (max 500 mg/dose) for 10 days 5, 6
• Monitor for adverse effects, particularly musculoskeletal complaints in children 3

Alternative Salvage Options:

• Linezolid (effective against resistant Gram-positives but expensive and not FDA-approved for AOM) 1
• High-dose amoxicillin + rifampin (though rifampin should not be used >10-14 days due to rapid resistance development) 7

Common Pitfalls

1. Mistaking persistent middle ear effusion for treatment failure: 60-70% of children have effusion 2 weeks post-treatment; this is NOT an indication to change antibiotics 1

2. Using this combination as first-line therapy: This violates antibiotic stewardship principles and exposes patients to unnecessary fluoroquinolone risks

3. Ignoring the need for tympanocentesis: Culture data is critical when multiple antibiotics have failed 1

4. Failing to consider non-infectious causes: After multiple antibiotic failures, reassess the diagnosis—could this be otitis media with effusion, cholesteatoma, or another condition?

The combination of clindamycin and levofloxacin is a reasonable salvage option for multiply-resistant AOM, but only after exhausting standard therapies and ideally with culture guidance. The risks of fluoroquinolone use in children must be carefully weighed against the benefits in this specific clinical scenario 1, 3.